#National Institutes of Health

Researchers have been searching for agents that can wake HIV from its resting state in an effort to flush out the viral reservoir.

The American Cancer Society sets the record straight.

That’s the core message of an essay by Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases.

New forms of treatment and PrEP and, hopefully, an at least partially effective vaccine will be key to fighting the epidemic in the 2020s.

That’s the focus of one of three federal grants to research and address the island’s epidemic.

Last year, the federal agency invested nearly $300 million in the search for HIV cure therapies.

Over $12 million in grants has been awarded to the Wistar Institute to research the links between opioid receptors and immune activation.

Recently, ViiV Healthcare applied for approval of the first long-acting injectable HIV regimen.

This $14 million research project aims to find out. Here’s why it’s based in Miami.

The Mosaico study will enroll gay and bisexual men and transgender people at significant risk for the virus.

Investigators led by Scripps Research will study vaccines that coax the immune system into creating antibodies that protect against HIV.

Funding bills in the House prioritize Ryan White efforts, the Office of AIDS Research, opioid programs and more.

“It’s hard to be proud when your health is on the line and when stigma is beating you up,” said AIDS United’s Jesse Milan.

The NIH-funded research focuses on chronic conditions other than HIV and examines gender differences.

In a win for abortion opponents, the Trump administration limits funding of research using fetal tissue.

Federal researchers describe two paths to a vaccine—and one of them uses high-tech computers to design a vaccine candidate!